CHICAGO, IL—A shelf-stable blood product may be a reasonable alternative to frozen plasma in cardiac surgery patients who experience bleeding, the FARES-II trial suggests. The four-factor prothrombin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback